Growth Hormone Update 2026 is a comprehensive evidence-based educational program designed to help healthcare professionals and health-conscious individuals better understand the central role of the Growth Hormone (GH)/Insulin-like Growth Factor-1 (IGF-1) axis in healthy aging, performance, tissue repair, and longevity. Drawing from decades of endocrinology research and current scientific literature, this lecture explains the neuroendocrine regulation of GH, the critical functions of IGF-1 and the insulin-like growth factor binding proteins (IGFBPs), and the laboratory evaluation of GH deficiency.
Participants will explore the physiology of natural GH secretion, factors that stimulate or inhibit its production, the emerging role of GH secretagogues and peptide therapies, and practical clinical strategies for optimizing endogenous GH production while minimizing receptor desensitization. The lecture also addresses one of the most controversial topics in endocrinology—the relationship between Growth Hormone and cancer—reviewing the protective roles of IGFBP-3, IGFBP-4, p53, apoptosis, and current scientific evidence surrounding cancer risk.
Through clinical case discussions and practical treatment concepts, attendees will gain a deeper understanding of how the GH/IGF-1 system influences cognition, immune function, cardiovascular health, body composition, musculoskeletal integrity, metabolic health, and overall quality of life.
Whether your interest is precision medicine, functional endocrinology, regenerative medicine, or healthy aging, Growth Hormone Update 2026 provides a balanced, science-driven review of one of the body's most influential hormonal systems and its application to modern clinical practice.
